Publications (2)4.6 Total impact

  • Gao Wei · Ren Yaqi · Wang Ningfu · Hou Xuwei
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the prognostic value of N-terminal prohormone B-type natriuretic peptide (NT-proBNP) for patients with stable coronary artery disease, we searched for all published English-language articles indexed in MEDLINE and PubMed through July 2011. Nine independent, prospective, cohort studies that assessed the association between NT-proBNP value and long-term prognosis were identified. The interested endpoints of this meta-analysis were all-cause mortality and cardiovascular mortality and cardiovascular events. A general variance-based method was used to pool the hazard ratio (HR). In a comparison of individuals in the top quartile with those in the bottom quartile of baseline values of NT-proBNP, the combined adjusted HR was 2.74 (95% confidence interval [CI], 1.85-3.62). The combined HRs for the second and third quartiles compared with the first quartile were 1.33 (95% CI, 0.83-1.82) and 1.85 (95% CI, 1.23-2.48), respectively. In a subanalysis grouped by the median value, per 1 standard deviation increase or per 1000 pg/mL increase of NT-proBNP, the overall effect also showed that poor prognosis was significantly increased with the elevation of NT-proBNP (HR, 1.58; 95% CI, 1.16-2.01). Available prospective studies indicated strong associations between the circulating concentration of NT-proBNP and long-term prognosis in patients with stable coronary artery disease.
    Reviews in cardiovascular medicine 01/2013; 14(2-4):e92-8. DOI:10.3909/ricm0644 · 0.56 Impact Factor
  • Gao Wei · Yuan Fang · Ren Yaqi · Chen Lin · Wang Ningfu
    International journal of cardiology 03/2012; 157(1):152-6. DOI:10.1016/j.ijcard.2012.03.020 · 4.04 Impact Factor